Heqet Therapeutics
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $8.7M
Investors
- 2
About Heqet Therapeutics
Based in Turin, Italy, Heqet Therapeutics operates as a provider of healthcare platform that targets the treatment of cardiovascular diseases. The company creates cutting-edge genetic therapeutics to combat the effects of ischemic heart disease.
Who invested in Heqet Therapeutics
2 investors across 1 round
See all investors in Heqet Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 23, 2022
Amount
$8.7M
Investors
Questions about Heqet Therapeutics
Who invested in Heqet Therapeutics?
Heqet Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Heqet Therapeutics raised?
Heqet Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Heqet Therapeutics last raise money?
Heqet Therapeutics's most recent round on record is a Series A, in Mar 2022.
What does Heqet Therapeutics do?
Based in Turin, Italy, Heqet Therapeutics operates as a provider of healthcare platform that targets the treatment of cardiovascular diseases.
Where is Heqet Therapeutics headquartered?
Heqet Therapeutics is headquartered in Turin, Italy.
Which VCs invest in companies like Heqet Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Heqet Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Heqet Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.